NRAS-mutant melanoma: response to chemotherapy

Arch Dermatol. 2011 May;147(5):626-7. doi: 10.1001/archdermatol.2011.85.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Dacarbazine / analogs & derivatives*
  • Dacarbazine / therapeutic use
  • Female
  • Genes, ras / genetics*
  • Humans
  • Male
  • Melanoma / drug therapy
  • Melanoma / genetics*
  • Mutation*
  • Proto-Oncogene Proteins p21(ras)
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / genetics*
  • Temozolomide

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Proto-Oncogene Proteins p21(ras)
  • Temozolomide